Drug Industry Leaders See Collaboration as Key to Greater Productivity, According to Tufts Center for the Study of Drug Development
August 13, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Aug 13, 2013) - Responding to a widely shared need to improve the probability of R&D success, leaders from the research-based drug industry, recently convened by...
Number of Annual New Drug Approvals to Treat Neglected Diseases Has Nearly Doubled Between the Early-2000s and 2009-12, According to the Tufts Center for the Study of Drug Development
July 11, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Jul 11, 2013) - The annual number of new drug approvals worldwide to treat neglected diseases has nearly doubled in recent years, with HIV/AIDS and malaria drugs...
Clinical Success Rates for New Cancer Drugs Doubled From the Mid-1990s to Early-2000s, According to the Tufts Center for the Study of Drug Development
May 07, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - May 7, 2013) - Clinical success rates for new cancer drugs doubled between the mid-1990s to the early 2000s, while the number of new cancer drugs entering clinical...
New Protocol Design Approaches Will Improve Clinical Trial Performance and Efficiency, According to Tufts Center for the Study of Drug Development
April 09, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Apr 9, 2013) - Growing protocol complexity -- responsible for longer clinical study times, greater difficulty in recruiting volunteers, and rising drug development costs...
Peter MacCallum Cancer Centre Implements Clarity LIMS
March 12, 2013 07:00 ET
|
GenoLogics Life Sciences Software Inc
Melbourne, Australia, March 12, 2013 (GLOBE NEWSWIRE) -- GenoLogics Life Sciences Software, a leading provider of
laboratory information management systems (LIMS) specifically
designed for omics labs,...
Companion Diagnostics, Key to Development of Personalized Medicines, Face Hurdles, According to Tufts Center for the Study of Drug Development
January 24, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 24, 2013) - Companion diagnostics, which are central to the creation of personalized medicines, have captured the interest of many drug companies, but face a number of...
New Research From Tufts Center for the Study of Drug Development Characterizes Effectiveness and Variability of Patient Recruitment and Retention Practices
January 15, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 15, 2013) - While nine out of 10 clinical trials worldwide meet their patient enrollment goals, reaching those targets typically means that drug developers need to...
Drug Developers Need to More Fully Identify and Address Root Causes of R&D Inefficiency, According to Tufts Center for the Study of Drug Development
January 08, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 8, 2013) - While patent expirations on many top selling medicines are spurring the research-based drug industry to embrace new development paradigms to replenish...
Extraneous Data Collected in Clinical Trials Cost Drug Developers $4 Billion to $6 Billion Annually, According to Tufts Center for the Study of Drug Development
November 06, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Nov 6, 2012) - One out of every five procedures performed during later stage clinical trials collects extraneous data and costs drug developers more than $1 million per...
Contract Support and Technical Service Providers Expected to Play a Growing Role in Drug Development, According to Tufts Center for the Study of Drug Development
October 17, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Oct 17, 2012) - Drug sponsors and their contract service providers are using more sophisticated, integrated, and coordinated relationship structures to deliver greater...